Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02145403
What this trial is testing

Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesRelapseGraft-Versus-Host Disease
University of Michigan Rogel Cancer Center 53
Not applicableNot Yet RecruitingNCT06741813
What this trial is testing

Allo-HSCT vs ASCT in Adult T-LBL

Who this might be right for
T Lymphoblastic Lymphoma
Peking University People's Hospital 230
Testing effectiveness (Phase 2)Ended earlyNCT04118556
What this trial is testing

Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT

Who this might be right for
GVHD, Acute
Mats Remberger 12
Large-scale testing (Phase 3)UnknownNCT04123392
What this trial is testing

Decitabine + BUCY vs BUCY Conditioning Regimen for TP53+ Myeloid Tumors Undergoing Allo-HSCT

Who this might be right for
TP53Myeloid TumorsConditioning+1 more
Nanfang Hospital, Southern Medical University 196
Testing effectiveness (Phase 2)Ended earlyNCT05447663
What this trial is testing

Siremadlin Alone and in Combination With Donor Lymphocyte Infusion in Acute Myeloid Leukemia Post-allogeneic Stem Cell Transplant

Who this might be right for
Acute Myeloid LeukemiaAllogeneic Stem Cell Transplantation
Novartis Pharmaceuticals 8
Testing effectiveness (Phase 2)Study completedNCT05991973
What this trial is testing

Low-dose Chidamide Maintenance Therapy After Allo-HSCT for T-cell Acute Lymphoblastic Leukemia or T-cell Lymphomas

Who this might be right for
T Lymphoblastic Leukemia/Lymphoma
Zhejiang University 44
Post-approval studies (Phase 4)UnknownNCT05379569
What this trial is testing

Comparative Study of BFC and BuCy Conditioning Regimen for Allo-PBSCT in Acute B-cell ALL

Who this might be right for
Acute B Lymphoblastic LeukemiaAllogeneic Hematopoietic Stem Cell Transplantation
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 142
Not applicableStudy completedNCT04342442
What this trial is testing

Identification of Novel Targetable Kinases in SR-a GvHD

Who this might be right for
Graft Versus Host Disease
University of Freiburg 24
Testing effectiveness (Phase 2)UnknownNCT05823714
What this trial is testing

Venetoclax+Azacytidine+Modified BUCY Conditioning Regimen for Acute Myeloid Leukemia and Myelodysplastic Syndromes Undergoing Allo-HSCT

Who this might be right for
Allogeneic Hematopoietic Stem Cell TransplantationAcute Myeloid LeukemiaMyelodysplastic Syndrome
The First Affiliated Hospital of Soochow University 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT00544466
What this trial is testing

Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

Who this might be right for
LeukemiaMyelodysplastic Syndromes
City of Hope Medical Center 75
Not applicableUnknownNCT06022445
What this trial is testing

Prospective Validation of CARPET Prognostic Model for Septic Shock After Allo-HSCT

Who this might be right for
Stem Cell Transplant Complications
Peking University People's Hospital 200
Testing effectiveness (Phase 2)Ended earlyNCT03948529
What this trial is testing

RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

Who this might be right for
LeukemiaGraft Failure
University Hospital, Lille 9
Large-scale testing (Phase 3)Study completedNCT02744742
What this trial is testing

G-CSF+Decitabine+BUCY vs BUCY Conditioning Regimen for RAEB-1, REAB-2 and AML Secondary to MDS Undergoing Allo-HSCT

Who this might be right for
Myelodysplastic SyndromeAllogeneic Hematopoietic Stem Cell TransplantationConditioning
Nanfang Hospital, Southern Medical University 202
Very early researchNot Yet RecruitingNCT07201727
What this trial is testing

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
AML - Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Not applicableStudy completedNCT04038827
What this trial is testing

Origin of CEC in Patients After Allo-HSCT

Who this might be right for
Graft Versus Host Disease, AcuteEndothelial DysfunctionImmune Tolerance
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 15
Large-scale testing (Phase 3)UnknownNCT04674345
What this trial is testing

Sorafenib Maintenance for Prophylaxis of Leukemia Relapse in Allo-HSCT Recipients With FLT3 Negative Acute Leukemia

Who this might be right for
Acute LeukemiaRelapseHematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 346
Not applicableUnknownNCT05596981
What this trial is testing

The Gut Microbiome in FLT3-ITD+ AML Undergoing Allo-HSCT With Or Without Sorafenib Maintenance After Allo-HSCT

Who this might be right for
Acute Myeloid Leukemia With FLT3/ITD MutationAllogeneic Hematopoietic Stem Cell Transplantation
Nanfang Hospital, Southern Medical University 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT06171906
What this trial is testing

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
MSC
ShiCang Yu 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT03597321
What this trial is testing

Early Prophylactic Donor Lymphocyte Infusion After Allo-HSCT for Patients With AML

Who this might be right for
Acute Myeloid Leukemia
Institut Paoli-Calmettes 124
Post-approval studies (Phase 4)Looking for participantsNCT07569653
What this trial is testing

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Who this might be right for
Cytomegalovirus InfectionsCytomegalovirus DiseaseHematopoietic Stem Cell Transplantation+1 more
WeiShi 120
Next Page